Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...

Researchers at The University of Colorado Anschutz Medical Campus and colleagues at Massachusetts General Hospital, have ...

Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...

Why African American communities are more at risk for diabetes and how to manage it.

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 ...

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...

A new study reveals a strong connection between red and processed meat consumption and type 2 diabetes risk. Researchers ...

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...